• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Autoantibodies may precede symptom onset in Sjögren’s Syndrome

bys25qthea
January 17, 2014
in Chronic Disease, Infectious Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. 66% of patients with Sjögren’s Syndrome (SS) in this study had autoantibodies detected in the serum prior to symptom onset and diagnosis of SS. 

2. Multiple autoantibodies were present in serum prior to SS diagnosis, but this study did not find any significant differences between time from a positive test to symptom onset. 

Evidence Rating Level: 3 (Average)  

Study Rundown: Sjögren’s Syndrome (SS) is an autoimmune disease that attacks exocrine glands causing dry mouth and dry eyes among other symptoms.  Clinically, SS has important implications on oral health, digestive health, and has been found to increase the risk of certain lymphomas.  Multiple autoantibodies have been found in the serum of SS patients, but little research has explored positive serologies before SS onset.  This study included 44 individuals (41 females and 3 males) from the registry of SS patients from Malmö University Hospital in Malmö, Sweden. The authors found that 66% of SS cases had detectable autoantibodies before clinical diagnosis of SS.  They found no statistically significant difference in time from positive test to symptom onset.  The odds ratio for developing SS after a positive serum autoantibody test was highest for anto-Ro60/SSA and anti-La/SSB. A strength of this paper is the relatively long time period for which serologies were available for patients.  Weaknesses of the paper include the small sample size and the use of self-reported time of symptom onset.  Ultimately, larger studies with more individuals will be needed to determine the utility of serum autoantibodies as screening tools for SS.

Click to read the study, published today in JAMA

Relevant Reading: American College of Rheumatology Classification Criteria for Sjögren’s Syndrome: A Data-Driven, Expert Consensus Approach in the SICCA Cohort

RELATED REPORTS

Respiratory syncytial virus (RSV) vaccine produces transplacental neutralizing antibodies in pregnant women

#VisualAbstract: Ianalumab shows a dose-related improvement in disease activity in Sjögren’s syndrome without serious adverse events

Ianalumab shows a dose-related improvement in disease activity in Sjögren’s syndrome

In-Depth [retrospective cohort study]: This study included 44 individuals from the registry of SS patients at Malmö University Hospital and 44 matched controls. Twenty nine (66%) individuals had at least one of five positive serologies—ANA, rheumatoid factor IgM (RF), anti-Ro60/SSA, anti-Ro52/SSA, anti-La/SSB—prior to clinical diagnosis of SS. The median time period between detectable autoantibodies and symptom onset was 5 years for ANA, 6 years for RF, 4 years for Ro60/SSA, 5 years for Ro52/SSA, and 4 years for La/SSB.  These time periods were not statistically significant (p=0.41).  The odds ratio for developing SS with elevated autoantibodies was highest for anti-Ro60/SSA and anti-La/SSB (OR 15.0, 95% CI 1.9-118.5 and OR 10.0, 95% CI 1.2-81.5, respectively).  The odds ratio for being diagnosed with SS was 5.8 (95% CI 1.8-18.0) with an elevated ANA and was 4.5 (95% CI 1.4-14.4) with an elevated RF.

By Jeffrey Cohen and Brittany Hasty

More from this author: Most physicians point to others to control healthcare costs, QRS morphology and duration associated with cardiac resynchronization outcomes, Repeat bone mineral density testing may not improve prediction of fracture outcomes, Stent type may not be related to adverse cardiac events after surgery, Risk-reduction counseling with HIV testing may not decrease rates of sexually transmitted infections

©2012-2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

 

Tags: antibodiesSjögren’s Syndrome
Previous Post

Healthy dietary habits at midlife associated with better aging past 70

Next Post

Operating the night before daytime surgery appears to have no effect on safety

RelatedReports

Clinical practice guidelines linked to improved bronchiolitis outcomes
Infectious Disease

Respiratory syncytial virus (RSV) vaccine produces transplacental neutralizing antibodies in pregnant women

May 13, 2022
#VisualAbstract: Convalescent plasma is not effective at improving clinical outcomes or reducing mortality of COVID-19 patients not on mechanical ventilation
StudyGraphics

#VisualAbstract: Ianalumab shows a dose-related improvement in disease activity in Sjögren’s syndrome without serious adverse events

February 3, 2022
Autoantibodies may precede symptom onset in Sjögren’s Syndrome
Chronic Disease

Ianalumab shows a dose-related improvement in disease activity in Sjögren’s syndrome

January 26, 2022
#VisualAbstract: Nivolumab plus ipilimumab increases overall survival in patients with malignant pleural mesothelioma
StudyGraphics

#VisualAbstract: Positive Anti-Spike or Anti-Nucleocapsid Antibody Status is Associated with Reduced Incidence of SARS-CoV-2 Reinfection in Health Care Workers

February 17, 2021
Next Post
Complications 4.5x more frequent in hernias repaired laparoscopically vs. open repair

Operating the night before daytime surgery appears to have no effect on safety

Assisted conception not associated with increased pediatric cancer risk

Assisted conception not associated with increased pediatric cancer risk

High BMI linked to reduced risk of endometriosis

Higher BMI in girls correlated with early pubertal development

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.